蛋白

重组豚鼠肿瘤坏死因子甲蛋白, CF

5035-TG-025/CF

25微克

423美元

5035-TG/CF

5035-TG-025/CF

重组豚鼠肿瘤坏死因子甲蛋白, CF

The Recombinant Guinea Pig TNF-alpha Protein, CF from R&D Systems is derived from E. coli. The Recombinant Guinea Pig TNF-alpha Protein, CF has been validated for the following applications: Bioactivity.

肿瘤坏死因子甲

蛋白和酶

25微克

Supplied as a 0.2 µm filtered solution in PBS.

未共轭

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

豚鼠

17.4 kDa

Measured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. Matthews, N. and M.L. Neale (1987) in Lymphokines and Interferons, A Practical Approach. Clemens, M.J. et al . (eds): IRL Press. 221. The ED50 for this effect is 0.015-0.06 ng/mL.

<0.01 EU per 1 µg of the protein by the LAL method.

P51435

Bioactivity

E. coli-derived Recombinant Guinea Pig TNF-alpha Protein

423美元

APC1 protein, Cachectin, Cachetin, DIF, TNF, TNF, monocyte-derived, TNF-a, TNFA, TNFalpha, TNF-alphacachectin, TNFATNF, macrophage-derived, TNFG1F, TNFSF1A, TNFSF2, TNFSF2TNF superfamily, member 2, tumor necrosis factor, tumor necrosis factor (TNF superfamily, member 2), tumor necrosis factor alpha, Tumor necrosis factor ligand superfamily member 2, tumor necrosis factor-alpha

12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after opening. 3 months, <= -20 °C under sterile conditions after opening.